RxDoctor Payments DataLook up a doctor →

Girish Munavalli, MD

MOHS-Micrographic Surgery · Charlotte, NCNPI 1215910336

Payments from drug & device makers

$539,805in general payments, 2019–2025

Across 223 payments — averaging $2420.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$346K
  • Merz North America, Inc.$85K
  • Avita Medical Americas, LLC$36K
  • Dermira, Inc.$18K
  • Solta Medical, A Division Of Bausch Health US, LLC$15K
  • Lumenis BE Inc$9K
  • plus $31K from 23 others
$1,113in research payments, 2019–2025

Across 7 payments — averaging $159.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$820
  • Biofrontera Inc.$293

What the payments were for

  • Consulting fees$67,03557%
  • Speaking & faculty fees$32,19327%
  • Travel & lodging$4,8274%
  • Food & beverage$13,60412%
  • Education$2810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$539,805 in reported general payments places this provider in the 95th percentile of 50 mohs-micrographic surgery providers in North Carolina.

See all mohs-micrographic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$410,144
Medicare patients
438
Services billed
1,550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate256$1,852
Mupirocin68$404
Cefadroxil23$295
Ketoconazole13$165
ValacyclovirValacyclovir Hcl19$115
Triamcinolone Acetonide18$87
Tramadol Hcl57$70
Spironolactone15$59
Prednisone18$26

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →